The Annals of Internal Medicine published an intriguing essay online last week about tight glycemic control in type 2 diabetes. Its authors argue that we’ve got it all wrong: imposing tight controls is only subjecting patients to stresses — related to the complexities and costs of treatment — that make control less likely to succeed. In addition, the supposed benefits of that control haven’t been confirmed by the available evidence. They advocate a backing-off of the current stern limits, which might make visits to clinicians feel less like a visit to the principal’s office. Listen in on a conversation with Dr. Victor Montori, one of the essay’s coauthors.
As always, you are invited to weigh in with your own thoughts. Leave us a piece of your mind at 1-617-440-4374.
This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.